Monsanto Company (NYSE:MON) was less active in the last trading session as around 1.98 million shares exchanged hands on Wall Street, representing a decrease from its normal capacity of 3.81 million shares. A 0.04% change after the initial price of $125.32, sent the closing price to $125.49.Monsanto Company (MON) Analyst Opinion
Monsanto Company has a consensus hold rating from 16 Wall Street analysts, and the number of shares currently sold short amount to at least 1.55% of shares outstanding. The stock spiked 0.43% last month and is up 7.46 this year. Wall Street is only getting more bullish on the stock, with 3 of analysts who cover MON having a buy-equivalent rating. Analysts have placed a $126.4 price target on Monsanto Company, suggesting a 0.73% gain from recent close. It’s currently trading about -1.03% below its 52-week high.
Monsanto Company (MON) failed to surprise the stock market in its last reported earnings when it earned $3.22 a piece versus the consensus-estimated $3.3. Its revenue totaled $5.34 billion up 100.86% from the previous quarter.Monsanto Company (NYSE:MON) Intraday View
This stock (MON) is ahead of its 52-week low with 9.9%. Its last month’s stock price volatility remained 0.31% which for the week stands at 0.4%. The share price has moved forward from its 20 days moving average, trading at a distance of 0.37% and stays 2.5% away from its 50 days moving average. Over the last five days, shares have managed 0.48% gains and now is up 4.62% since hitting its 200-day moving average of $120.51. Monsanto Company (MON) has made its way to a 12-month gain of 8.35%.
Turning to Leggett & Platt, Incorporated (NYSE:LEG), its shares were trading at $41.88 a gain of $0.12, on the trading floor. The stock, after opening at $41.8, touched a high of $42 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.3. Leggett & Platt, Incorporated has 1 buy ratings, 3 holds and 0 sells even after the stock tumbled -22.39% from its high of $53.96 to a $5.48 billion market value through last close.
The company’s consensus rating on Reuter’s scale improved from 2.25 to 2.29 during a month. Analysts set a 12-month price target of $52.71 a share. The target implies a 25.86% spike from where the shares are currently trading. Also, the current price highlights a discount of 57.59% to analysts’ high consensus price target.
The counter witnessed a trading volume of 1.6 million shares versus an average volume of 1.44 million shares during last trading session. Its last month’s stock price volatility remained 1.08% which for the week approaches 2.05%. The lowest price the stock reached in the last trading day was $41.55 and compares with the $39.57 52-week low. The stock recovered 5.84% since its low point and has performed -12.26% year-to-date.